CAS No. |
1137648-52-2 |
|---|---|
中文名称 |
3,12-二羟基-4,6a,6b,11,11,14b-六甲基-8a-(((3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧)羰基)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-二十氢并苯并菲-4-羧酸 |
英文名称 |
3,12-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-(((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4-carboxylic acid |
别名 |
Ilexhainanoside D;Olean-12-ene-23,28-dioic acid, 3,19-dihydroxy-, 28-β-D-glucopyranosyl ester, (3β,4β,19α)- |
标准英文名 |
3,12-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-(((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4-carboxylic acid |
MDL No. |
- |
分子式 |
C36H56O11 |
分子量 |
664.83 |
精确分子量 |
664.38 |
SMILES |
CC1(C)CCC2(C(=O)OC3OC(CO)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C(=O)O)C5CCC43C)C2C1O |
标准SMILES |
CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C5CCC34C)C(O)=O)C2C1O)C(=O)OC1OC(CO)C(O)C(O)C1O |
用途 |
Ilexhainanoside D, in combination with Ilexsaponin A1, exhibits anti-inflammatory effects and ameliorates non-alcoholic fatty liver disease (NAFLD) induced by a high-fat diet in a dose-dependent manner; it modulates gut microbiota composition by decreasing the Firmicutes/Bacteroidetes ratio and the relative abundance of Desulfovibrio, while increasing the relative abundance of Akkermansia; it improves intestinal barrier function by upregulating the expression of zonula occludens-1 (ZO-1) and occludin in the ileum; and it reduces circulating lipopolysaccharide (LPS) levels and suppresses hepatic expression of proinflammatory cytokines. |
InChIKey |
PWXPWSCNXVCOCA-UHFFFAOYSA-N |
|
|
评论 |
|---|